ARTICLE | Clinical News
Neupro rotigotine regulatory update
December 10, 2007 8:00 AM UTC
EMEA accepted for filing an MAA from UCB for Neupro rotigotine to treat restless legs syndrome. The dopamine D2 receptor agonist patch is approved in the EU and U.S. to treat Parkinson's disease (PD)...